Amylx Pharmaceuticals Inc vs Aon PLC — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Aon PLC trades at $356.48 (market cap $75.61B). The key difference: Aon PLC is far larger — about 28.6× Amylx Pharmaceuticals Inc's market cap, and Aon PLC pays a 0.92% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | AON | |
|---|---|---|
Market Cap | $2.64B | $75.61B |
Sector | Health | Financials |
52-Week High | $24.19 | $381.26 |
52-Week Low | $7.82 | $308.22 |
Enterprise Value | $2.39B | $90.22B |
Dividend Yield | — | 0.92% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Aon is a leading global provider of insurance and reinsurance brokerage and human resource solutions. Its operations are tilted toward its brokerage operations. Headquartered in London, Aon has about 50,000 employees and operations in 120 countries around the world.
Read more on AON →